Persistent Cutaneous Symptoms in Patients With Long COVID
The effects of “long COVID” on the skin are reviewed.
The effects of “long COVID” on the skin are reviewed.
Findings from a retrospective chart review showed a need to carefully monitor inflammatory biomarkers and anticoagulant dosage in patients with severe COVID-19.
For patients with sickle cell disease, HSCT may not be associated with a significant increase in CKD incidence or prevalence following transplantation.
Investigators assess underlying mechanisms and relevant biomarkers of morbidity and mortality due to coagulopathy in patients with severe COVID-19 infection.
A team of investigators sought to determine whether endotheliopathy is involved in COVID-19–associated coagulopathy pathogenesis.
Although the association between thrombocytosis in iron deficiency anemia is understood, researchers studied the risk for thrombotic complications.
Six months after hematopoietic stem cell transplantation, nearly 20% of enrolled patients had experienced clinically significant PTSD symptoms.
The investigators sought to describe HRQOL and treatment satisfaction of ibrutinib-treated patients with CLL in the real-world setting.
Increased neutrophils in the colonic mucosa of patients with UC were associated with increased use of systemic corticosteroids, colectomy, and hospitalization during 3 years of follow-up.
Prospective studies are needed to determine what changes are significantly associated with treatment, whether these changes are causes or effects of response, and whether the composition of the intestinal microbiome can be used to select treatments for patients with IBD.